Ashton Thomas Private Wealth’s GSK GSK Stock Holding History

Ashton Thomas Private Wealth’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$3.97M	Buy	82,373 +2,686	+3%	+$137K	0.08%	248
2026 Q2	$4.18M	Buy	79,687 +9,570	+14%	+$506K	0.09%	233
2026 Q1	$3.87M	Buy	70,117 +9,336	+15%	+$506K	0.09%	234
2025 Q4	$3.01M	Sell	60,781 -33	-0.1%	-$1.54K	0.07%	262
2025 Q3	$2.65M	Buy	60,814 +229	+0.4%	+$8.94K	0.07%	277
2025 Q2	$2.34M	Buy	60,585 +41,430	+216%	+$1.58M	0.08%	250
2025 Q1	$750K	Sell	19,155 -586	-3%	-$21.5K	0.03%	454
2024 Q4	$675K	Buy	+19,741	New	+$711K	0.03%	473
2024 Q3	–	Sell	-952	Closed	-$36.7K	–	1120
2024 Q2	$36.7K	Buy	+952	New	+$40K	﹤0.01%	999

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

JTC Employer Solutions Trustee St Helier, Jersey $1.16B AUM 24.39% 1-Year Est. Return

Mondrian Investment Partners London, United Kingdom $5.39B AUM 14.53% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return

Equity Investment Corp Atlanta, Georgia $5.3B AUM 8.71% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $57.2B AUM 42.49% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $313B AUM 26.62% 1-Year Est. Return

Ashton Thomas Private Wealth's GSK Position: Q3 2026 in Review

Ashton Thomas Private Wealth increased its GSK (GSK) stake by 3.4% in Q3 2026, buying an estimated $137K and bringing the position to 82,373 shares worth $3.97M. The position accounts for 0.08% of the portfolio, ranked #248.

Ashton Thomas Private Wealth first reported a position in GSK in Q2 2024 and has held it in 9 quarters since. The position peaked at $4.18M in Q2 2026. 654 funds tracked by Wall St. Rank hold GSK as of Q3 2026.

Ashton Thomas Private Wealth held 82,373 shares of GSK worth $3.97M as of Q3 2026.
Ashton Thomas Private Wealth bought 2,686 GSK shares in Q3 2026, an estimated $137K.
GSK made up 0.08% of Ashton Thomas Private Wealth's portfolio in Q3 2026, its #248 holding.
Ashton Thomas Private Wealth first reported a position in GSK in Q2 2024 and has held it in 9 quarters since.
Ashton Thomas Private Wealth's GSK position peaked at $4.18M in Q2 2026.
654 funds tracked by Wall St. Rank held GSK as of Q3 2026.

Based on Ashton Thomas Private Wealth's 13F filing for Q3 2026, filed 3 Nov 2026.